Skip Navigation



Carcinogenesis Advance Access published online on April 29, 2007

Carcinogenesis, doi:10.1093/carcin/bgm105
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
28/9/1885    most recent
bgm105v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Saegusa, M.
Right arrow Articles by Okayasu, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saegusa, M.
Right arrow Articles by Okayasu, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A functional role of Cdx2 in ß-catenin signaling during trans-differentiation in endometrial carcinomas

Makoto Saegusa1, Miki Hashimura1, Takeshi Kuwata2, Mieko Hamano3, Yoji Wani4 and Isao Okayasu1

1 Department of pathology
3 Division of Cell Tissue Culture, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan
2 Department of carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo, Japan
4 Department of Pathology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, 710-8602, Japan

Correspondence to Makoto Saegusa, M.D. TEL:+81-42-778-8996; FAX:+81-42-778-8441;e-mail: msaegusa{at}med.kitasato-u.ac.jp

Nuclear ß-catenin is required for charges in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14ARF/p53/p21waf1 and alteration of p16INK4A/pRB pathways. Having demonstrated previously that the homeodomain transcription factor Cdx2 increases markedly during intestinal epithelial cell differentiation, we have examined its effects in ß-catenin signaling during trans-differentiation of Em Ca cells. In clinical cases, Cdx2 immunoreactivity, along with increased mRNA signals, was found to overlap with nuclear accumulation of ß-catenin and p21Waf1 in morules, demonstrating an inverse correlation with cell proliferation. In cell lines, overexpression of active form ß-catenin resulted in a significant increase in endogenous Cdx2 expression at both mRNA and protein levels. Furthermore, the Cdx2 promoter was activated by TCF4-independent activated ß-catenin, as well as Cdx2 itself, through the region from-39 to +9 bp relative ti transcription start site. Cells overexpressinig exogenous Cdx2 showed high levels of p21Waf1 expression due to stabilization of the mRNA status, resulting in significant decrease in the proliferation rate, in contrast to the lack of apparent changes in morphology. Moreover, transfected Cdx2 could inhibit ß-catanin/TCF4-mediated transcriptional activation of target genes, including p14ARF and cyclin D1, probably through indirect mechanisms. These data suggest that overexpression of Cdx2 mediated by nuclearß-catenin and Cdx2 itself can cause an inhibition of Em Ca cell proliferation through upregulation of p21Waf1 expression, modulating ß-catenin/TCF4-mediated transcription. We therefore conclude that an association between Cdx2 and ß-catenin signaling may participate in induction of trans-differentiation of Em Ca cells.

Received January 23, 2007; revised March 31, 2007; accepted April 24, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.